¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼­¿ï¾Æ»êº´¿ø ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ 2019 KGOG Joint International Symposium : 2019-07-13

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼­¿ï¾Æ»êº´¿ø ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ 2019 KGOG Joint International Symposium : 2019-07-13
±³À°ÀÏÀÚ : 2019-07-13
±³À°Àå¼Ò : ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ ´ë°­´ç, ¼¼¹Ì³ª½Ç  
±³À°ÁÖÁ¦ : 2019 KGOG Joint International Symposium
ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸  
´ã´çÀÚ : KGOG
¿¬¶ôó : 02-512-5420  
À̸ÞÀÏ : koreagynonco@hanmail.net      
±³À°Á¾·ù : »êºÎÀΰú      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°­´ç 08:00~08:20 Recent advances in Surgical strategies for Gynecologic Cancers  ¹é¹ÎÇö(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°­´ç 08:20~08:40 Recent advances in Target therapy in Gynecologic Cancers  ½É½ÂÇõ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°­´ç 08:40~09:00 Recent advances in Radiotherapy in Gynecologic Cancers  Haitham M. Felimban(Security Forces Hospital) 
Åä·Ð 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°­´ç 09:00~09:10 Discussion  () 
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°­´ç 13:20~13:40 Current activity of AMC Clinical Trials  ¹ÚÁ¤¿­(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°­´ç 13:40~14:00 Current activity of JGOG Clinical Trials  Takayuki Enomoto(Niigata Univ) 
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°­´ç 14:00~14:20 Current activity of KGOG Clinical Trials  ±èÀçÈÆ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°­´ç 14:20~14:40 Immuno-Oncology clinical trials status for gynecology cancers: future strategy of pembrolizumab in the clinical trials and real practice ting  Haluska Paul(MSD) 
Åä·Ð 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°­´ç 14:40~15:00 Discussion  () 
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°­´ç 15:00~15:20 Recent Key Issues & Debates in the Gynecological Pathology  ±è±Ô·¡(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°­´ç 15:20~15:40 Next generation of Cancer Drugs in the field of Gynecologic Cancers  Munekage Yamaguchi(Kumamoto Univ.) 
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°­´ç 15:40~16:00 Advances in Lymphovenous Anastomosis for Lymphedema Treatment  È«ÁØÇ¥(¿ï»êÀÇ´ë) 
Åä·Ð 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ´ë°­´ç 16:00~16:10 Discussion  () 
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 4¼¼¹Ì³ª½Ç 16:30~16:45 What''s New and Background of Guideline of HGC  ±è¹Ì¼±(Â÷ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 4¼¼¹Ì³ª½Ç 16:45~17:00 How to identify HBOC & Lynch Syndrome in Gynecologic Cancer  ÀÌ¿µÀç(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 4¼¼¹Ì³ª½Ç 17:00~17:15 NGS: What It Is and How Does It Work?  ±è¹Î±Ô(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 4¼¼¹Ì³ª½Ç 17:15~17:30 Application of Hereditary Predisposition to Immunotherapy  ÀÓ¸íö(±¹¸³¾Ï¼¾ÅÍ) 
Åä·Ð 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 4¼¼¹Ì³ª½Ç 17:30~17:40 Discussion  () 
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 5¼¼¹Ì³ª½Ç 16:30~16:50 Sentinel Lymph Node Mapping in Cervical Cancer  ±èÁÖÇö(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 5¼¼¹Ì³ª½Ç 16:50~17:10 Sentinel Lymph Node Mapping in Endometrial Cancer  ¼­µ¿ÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 5¼¼¹Ì³ª½Ç 17:10~17:30 Two Step Sentinel Lymph Node Mapping in Endometrial Cancer  ±è»ó¿î(¿¬¼¼ÀÇ´ë) 
Åä·Ð 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ 5¼¼¹Ì³ª½Ç 17:30~17:40 Discussion  () 
±³À°½Ã°£ 07-13 ¼­¿ï¾Æ»êº´¿ø µ¿°ü6Ãþ ¼Ò°­´ç 15:00~16:00 Introduction and Clinial Trial Concept of GYN cancer : Review and Discussion  Haluska, Paul(MSD) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼­¿ï¾Æ»êº´¿ø ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ 2019 KGOG Joint International Symposium : 2019-07-13""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2019 ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ Ãá°èÇмú´ëȸ : 2019-07-13
´ÙÀ½±Û ÀüºÏ´ëÇб³º´¿ø ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ 2019³â »ï³²Áöȸ ½ÉÆ÷Áö¾ö : 2019-07-13
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 81 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 44 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 53 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 57 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 50 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 47 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 23 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 46 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 23 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 53 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 31 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 39 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 33 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷